查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529372

全球光医学技术市场 - 2024-2031

Global Photomedicine Technology Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球光医学技术市场规模达36亿美元，预计2031年将达到67亿美元，2024-2031年预测期间复合年增长率为8.2%。

被称为光医学的医学领域利用光和光生物学来治疗疾病。光医学技术用于一系列治疗和诊断应用。光医学技术比传统的疾病检测方法更先进，可用于治疗广泛的治疗领域，如肿瘤学、眼科、牙科、皮肤科疼痛管理等。

该市场的推动因素包括越来越多地采用先进的雷射治疗、美学意识的提高以及对非侵入性手术和技术进步的认识不断提高。

市场动态：

司机

越来越多采用先进的雷射治疗

全球光医学技术市场的需求是由多种因素所驱动的。雷射治疗已经针对不同的皮肤病实施了新技术。烧蚀性和非烧蚀性雷射作用于表皮和真皮的不同层面，可以治疗许多皮肤病。

此外，雷射技术与人工智慧的融合将推动该市场的成长。根据 2024 年 1 月发布的 Asclepion 雷射技术出版物，人工智慧与雷射设备的整合预示着一个新时代的到来，为从业者提供前所未有的精度、效率和结果，无缝地实现患者的美学目标。

此外，该行业的主要参与者推出新的治疗方法和批准将推动该市场的成长。例如，2022 年 11 月，美国食品药物管理局 (FDA) 批准 Accure Acne, Inc. 的 Accure 雷射系统用于治疗轻度至重度发炎性寻常痤疮。 Accure 的系统是首款获得 FDA 和 CE 标誌许可的基于 1726 nm 的雷射设备。

此外，2024 年 4 月，ViaLase 宣布结束 4,000 万美元的融资系列，用于雷射技术的发展。开发执行飞秒雷射影像导引高精度小梁切除术的雷射系统。

限制

与治疗相关的不良反应和併发症、光医疗手术的高成本、缺乏熟练的专业人员以及有限的监管框架和报销政策等因素预计将阻碍市场。

有关此报告的更多详细资讯 - 索取样品

目录

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 越来越多采用先进的雷射治疗
      • 美感意识增强
      • 对非侵入性手术和技术进步的认识不断提高
    • 限制
      • 与治疗相关的不良反应和併发症
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 未满足的需求
  • PESTEL分析
  • 专利分析
  • SWOT分析

第 6 章：依技术分类

  • 光动力疗法
  • 光免疫疗法
  • 雷射器
  • 其他的

第 7 章：按申请

  • 美容与皮肤科
    • 除毛
    • 去除纹身
    • 皮肤换肤
    • 其他应用
  • 眼科
  • 牙科
  • 肿瘤学
  • 疼痛管理
  • 伤口癒合
  • 其他应用

第 8 章：最终用户

  • 医院和诊所
  • 美容中心
  • 学术界及研究机构
  • 其他的

第 9 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Candela Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Alma Lasers
  • Lumenis Be Ltd
  • PhotoMedex
  • biolitec Holding GmbH & Co KG
  • Beurer
  • Lumibird Medical
  • Koninklijke Philips NV
  • THOR Photomedicine Ltd
  • Johnson & Johnson

第 12 章：附录

简介目录
Product Code: MD1225

Overview

The global photomedicine technology market reached US$ 3.6 billion in 2023 and is expected to reach US$ 6.7 billion by 2031, growing at a CAGR of 8.2% during the forecast period 2024-2031.

The field of medicine known as photomedicine uses light and photobiology to treat diseases. Technologies in photomedicine are employed for a range of therapeutic and diagnostic applications. Photomedicine technologies are more advanced than traditional disease detection methods and are used to treat a wide range of therapy areas such as oncology, ophthalmology, dentistry, dermatology pain management, and others.

The market is driven by factors such as the increasing adoption of advanced laser-based treatments, increased awareness of aesthetics, and rising awareness about non-invasive procedures & technological advancements.

Market Dynamics: Drivers

Increasing adoption of advanced laser-based treatments

The demand for the global photomedicine technology market is driven by multiple factors. Laser treatments have been implemented over the new technologies available for different skin diseases. Ablative and non-ablative lasers act on different levels of the epidermis and dermis, allowing to treatment of many dermatological conditions.

Moreover, the integration of laser technology and artificial intelligence would drive this market growth. As per Asclepion laser technology publication in January 2024, the integration of AI with laser devices is indicating a new era, offering practitioners unprecedented precision, efficiency, and outcomes that seamlessly achieve their patients' aesthetic goals.

In addition, key players in the industry introducing new treatments and approvals would propel this market growth. For instance, in November 2022, the US Food and Drug Administration (FDA) cleared Accure Acne, Inc.'s Accure Laser System for the treatment of mild to severe inflammatory acne vulgaris. Accure's system is the first 1726nm-based laser device with both FDA and CE Mark clearances.

Also, in April 2024, ViaLase announces the closure of the financing series with $40 million for laser advancement. The development of a laser system that performs femtosecond laser image-guided high-precision trabeculectomy.

Restraints

Factors such as adverse effects & complications associated with the treatment, the high cost of photomedicine procedures, lack of skilled professionals, and limited regulatory framework & reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global photomedicine technology market is segmented based on technology, application, end-user, and region.

The oncology segment accounted for approximately 54.6% of the global photomedicine technology market share

The oncology segment is expected to hold the largest market share over the forecast period. Skin carcinoma is one of the most dangerous types of cancer & fifth most commonly reported cancer in the world. As per BMC research publication in January 2023, the American Academy of Dermatology (AAD) disclosed that approximately 9,500 people in the United States were diagnosed with skin cancer every day in 2022.

In addition, key players in the market launching innovative technologies in treating various diseases and research studies would propel this market growth. According to an EurekAlert news release in December 2023, ultrafast laser technology could offer improved cancer treatment discovery by the Canadian research team at INRS could lead to more effective use of radiation therapy in oncology.

As per the AAAS publication in March 2022, Biologists and physicists at Lawrence Berkeley National Laboratory (Berkeley Lab) have teamed up to create new opportunities for cancer treatment using laser-generated proton beams.

Moreover, key players launching new products and approvals would drive this market growth. For instance, in January 2024, AngioDynamics, Inc. announced that the United States Food and Drug Administration (FDA) has cleared the Auryon XL Catheter, a 225-cm radial access catheter, for use with the Auryon Atherectomy System in the treatment of Peripheral Arterial Disease (PAD).

Geographical Analysis

North America accounted for approximately 43.4% of the global photomedicine technology market share

North America region is expected to hold the largest market share over the forecast period. The high incidence of skin disorders and cancers in North America, particularly in the United States, drives the demand for advanced photomedicine technologies. According to the American Cancer Society's 2022 update, there were an estimated 1.9 million new cancer cases in the United States, with breast cancer alone accounting for 290,560 new cases.

Moreover, side effects associated with cancer such as hair loss and skin problems drive this market growth. According to the American Hair Loss Association estimated that more than 80 million men and women are suffering from hair loss concerns in the US with a 400% increase in patient demand since the pandemic in 2022.

In addition, major players in this region launched new product launches, and approvals would drive this market growth. For instance, in March 2022, Alma announced the commercial launch of two game-changing additions to Alma's U.S. portfolio of products this year. Alma TED and CBD+ Professional Skincare Solution were launched at the American Academy of Dermatology.

Similarly, in April 2024, Bestqool launched an FDA class-II cleared, durable, and versatile variety of red light therapy (RLT), unique devices designed to handle various skin problems & have medical-grade product certification, like alleviating symptoms of eczema and improving skin health.

Also, in July 2021, Cytrellis announced that the U.S. Food and Drug Administration has cleared their first proprietary product, the ellacor system with Micro-Coring technology, for the treatment of moderate to severe wrinkles in the mid to lower face. This minimally-invasive, first-in-category device safely and effectively removes micro-sized portions of excess skin without surgery, thermal energy, or evidence of scarring.

Similarly, in January 2024, Iridex launches new Iridex 532 and Iridex 577 Lasers in the US market marking 35 years of laser innovation in treating retina disorders & glaucoma.

Market Segmentation

By Technology

  • Photodynamic Therapy
  • Photoimmune Therapy
  • Lasers
  • Others

By Application

  • Aesthetics & Dermatology
    • Hair Removal
    • Tattoo Removal
    • Skin Resurfacing
    • Other Applications
  • Ophthalmology
  • Dentistry
  • Oncology
  • Pain Management
  • Wound Healing
  • Other Applications

By End-use

  • Hospitals & Clinics
  • Cosmetic Centers
  • Academics & Research Institutions
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the photomedicine technology market include Candela Corporation, Alma Lasers, Lumenis Be Ltd, PhotoMedex, biolitec Holding GmbH & Co KG, Beurer, Lumibird Medical, Koninklijke Philips N.V., THOR Photomedicine Ltd, and Johnson & Johnson among others.

Key Developments

  • In May 2024, the Photomedicine to Enhance Military Readiness Program, a part of the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), was launched in 2018 with support from the Defense Health Agency to help prevent and treat musculoskeletal injuries.
  • In March 2024, Pioneering biopharmaceutical company CLINUVEL hosted a wide-ranging market briefing discussing its novel drug SCENESSE (afamelanotide) and the future of photomedicine.
  • In May 2022, Lumenis Be stated that OptiLight has received the highly competitive MedTech Breakthrough Award for "Best New Technology Solution for Ophthalmology."
  • In January 2021, TheraLight, LLC, announced that Health Canada has approved the TheraLight 360 full-body photobiomodulation system for use in Canada. Which incorporates next-generation light therapy technology for advanced pain relief and recovery.

Why Purchase the Report?

  • To visualize the global photomedicine technology market segmentation based on technology, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global photomedicine technology market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in Excel consisting of key products of all the major players.

The global photomedicine technology market report would provide approximately 62 tables, 62 figures, and 182 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Advanced Laser-based Treatments
      • 4.1.1.2. Increased Awareness of Aesthetics
      • 4.1.1.3. Rising awareness about non-invasive procedures & Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Adverse Effects & Complications Associated with the Treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Photodynamic Therapy *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Photoimmune Therapy
  • 6.4. Lasers
  • 6.5. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Aesthetics & Dermatology *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Hair Removal
    • 7.2.4. Tattoo Removal
    • 7.2.5. Skin Resurfacing
    • 7.2.6. Other Applications
  • 7.3. Ophthalmology
  • 7.4. Dentistry
  • 7.5. Oncology
  • 7.6. Pain Management
  • 7.7. Wound Healing
  • 7.8. Other Applications

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals & Clinics *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cosmetic Centers
  • 8.4. Academics & Research Institutions
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Candela Corporation *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio & Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Alma Lasers
  • 11.3. Lumenis Be Ltd
  • 11.4. PhotoMedex
  • 11.5. biolitec Holding GmbH & Co KG
  • 11.6. Beurer
  • 11.7. Lumibird Medical
  • 11.8. Koninklijke Philips N.V.
  • 11.9. THOR Photomedicine Ltd
  • 11.10. Johnson & Johnson

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us